Japan's PMDA Assesses Ethnic Factors On Clinical Data For Regional Trials – APEC Workshop
This article was originally published in PharmAsia News
You may also be interested in...
More Talks Needed With China and Japan For Cooperation In Sharing Clinical Data - Korea FDA Official
SEOUL - Although drug regulatory officials from South Korea, Japan and China met in Beijing for two days from Dec. 17 in their second tri-party meeting, they failed to report "noticeable progress" in their pursuit of an integrated clinical trial data-sharing program and mutual acceptance of their rules and guidelines, according to Korea FDA
The US Department of Justice, SEC and the Chinese government have all increased investigations of corrupt practices, and incriminating evidence is easier than ever to find. What can companies do to protect themselves?
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.